Targeting the Mycobacterium ulcerans cytochrome bc1:aa3 for the treatment of Buruli ulcer
出版年份 2018 全文链接
标题
Targeting the Mycobacterium ulcerans cytochrome bc1:aa3 for the treatment of Buruli ulcer
作者
关键词
-
出版物
Nature Communications
Volume 9, Issue 1, Pages -
出版商
Springer Nature
发表日期
2018-12-12
DOI
10.1038/s41467-018-07804-8
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Inhibition of Sec61-dependent translocation by mycolactone uncouples the integrated stress response from ER stress, driving cytotoxicity via translational activation of ATF4
- (2018) Joy Ogbechi et al. Cell Death & Disease
- Comparative Genomics Shows That Mycobacterium ulcerans Migration and Expansion Preceded the Rise of Buruli Ulcer in Southeastern Australia
- (2018) Andrew H. Buultjens et al. APPLIED AND ENVIRONMENTAL MICROBIOLOGY
- Exploiting the synthetic lethality between terminal respiratory oxidases to killMycobacterium tuberculosisand clear host infection
- (2017) Nitin P. Kalia et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Imidazo[1,2-a]Pyridine-3-Carboxamides Are Active Antimicrobial Agents against Mycobacterium avium InfectionIn Vivo
- (2016) Garrett C. Moraski et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Comparative Study of Activities of a Diverse Set of Antimycobacterial Agents against Mycobacterium tuberculosis and Mycobacterium ulcerans
- (2016) Nicole Scherr et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Locally Confined Clonal Complexes of Mycobacterium ulcerans in Two Buruli Ulcer Endemic Regions of Cameroon
- (2015) Miriam Bolz et al. PLoS Neglected Tropical Diseases
- Respiratory Flexibility in Response to Inhibition of CytochromecOxidase in Mycobacterium tuberculosis
- (2014) Kriti Arora et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Lead Optimization of a Novel Series of Imidazo[1,2-a]pyridine Amides Leading to a Clinical Candidate (Q203) as a Multi- and Extensively-Drug-Resistant Anti-tuberculosis Agent
- (2014) Sunhee Kang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Long Term Streptomycin Toxicity in the Treatment of Buruli Ulcer: Follow-up of Participants in the BURULICO Drug Trial
- (2014) Sandor Klis et al. PLoS Neglected Tropical Diseases
- Discovery of Q203, a potent clinical candidate for the treatment of tuberculosis
- (2013) Kevin Pethe et al. NATURE MEDICINE
- The genome, evolution and diversity of Mycobacterium ulcerans
- (2012) Katharina Röltgen et al. INFECTION GENETICS AND EVOLUTION
- Chemotherapy-Associated Changes of Histopathological Features of Mycobacterium ulcerans Lesions in a Buruli Ulcer Mouse Model
- (2011) Marie-Thérèse Ruf et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Antimicrobial treatment for early, limited Mycobacterium ulcerans infection: a randomised controlled trial
- (2010) Willemien A Nienhuis et al. LANCET
- A chemical genetic screen in Mycobacterium tuberculosis identifies carbon-source-dependent growth inhibitors devoid of in vivo efficacy
- (2010) Kevin Pethe et al. Nature Communications
- Genomic Diversity and Evolution of Mycobacterium ulcerans Revealed by Next-Generation Sequencing
- (2009) Weihong Qi et al. PLoS Pathogens
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started